CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Criteria for Iron Deficiency in Patients With Heart Failure Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure Noninvasive Imaging for the Evaluation of Diastolic Function: Promises Fulfilled

Clinical TrialFebruary 6, 2018, Volume 137, Issue 6

JOURNAL:Circulation Article Link

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

M .Kosiborod, CVD-REAL Investigators and Study Group. Keywords: SGLT2 inhibitor; death; diabetes mellitus; heart failure; observational studies

FULL TEXT PDF